Main Article Content
Lactulose is a common first-line therapy for acute and chronic hepatic encephalopathy, which is generally considered a safe medication and used liberally. This report aims to highlight an uncommon but serious side effect of using lactulose. A case study is presented of a severe and acute hypernatremia caused by lactulose therapy for acute hepatic encephalopathy precipitated by a transjugular intrahepatic portosystemic shunt procedure.
How to Cite
Mosli, H. H. (2012). Iatrogenic Severe Hypernatremia: A Case Report. Journal of King Abdulaziz University - Medical Sciences, 19(1), 129-134. https://doi.org/10.4197/Med.19-1.10
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.